# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 31-40 of 605 results.
ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK
Status: Recruiting
Last Changed: Jan 27, 2020
First Received: Sep 19, 2017
Disease(s): Ovarian Cancer
Intervention(s): VS-6063, Paclitaxel, Carboplatin
Locations: University of California San Diego, San Diego, California, United States
Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm
Status: Not yet recruiting
Last Changed: Jan 02, 2020
First Received: Jan 02, 2020
Disease(s): Ovarian Cancer
Intervention(s): Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm
Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3)
Status: Recruiting
Last Changed: Mar 25, 2020
First Received: May 07, 2019
Disease(s): Ovarian Cancer
Intervention(s): NovoTTF-100L(O), Paclitaxel
Locations: Arizona Oncology, Tucson, Arizona, United States
Des Moines Oncology Research Association, Des Moines, Iowa, United States
Maryland Oncology Hematology, P.A., Silver Spring, Maryland, United States
Minnesota Oncology Hematology, PA, Saint Paul, Minnesota, United States
Women's Cancer Center of Nevada, Las Vegas, Nevada, United States
... and 40 other locations.
China Ovarian Cancer BRCA Testing Study
Status: Recruiting
Last Changed: Mar 16, 2020
First Received: Jun 29, 2017
Disease(s): Ovarian Cancer
Locations: Research Site, BeiJing, China
Research Site, Changsha, China
Research Site, Chengdu, China
Research Site, Chongqing, China
Research Site, Guangzhou, China
... and 10 other locations.
Open Label Immunotherapy Trial for Ovarian Cancer
Status: Recruiting
Last Changed: Aug 30, 2019
First Received: Jun 14, 2018
Disease(s): Ovarian Cancer
Intervention(s): Tableted vaccine (V3-OVA) containing ovarian cancer antigens
Locations: Immunitor LLC, Ulaanbaatar, Mongolia
Niraparib Maintenance in Patients With Advanced Ovarian Cancer at Neoadjuvant Setting
Status: Not yet recruiting
Last Changed: Feb 26, 2020
First Received: Feb 26, 2020
Disease(s): Ovarian Cancer
Intervention(s): Niraparib
Locations: The University of Hong Kong, Hong Kong, Hong Kong
Clinical Impact of Dedicated MR Staging of Ovarian Cancer
Status: Recruiting
Last Changed: May 22, 2018
First Received: Jan 16, 2018
Disease(s): Ovarian Cancer
Intervention(s): MRI
Locations: NKI-AVL, Amsterdam, Netherlands
Prognostic and Predictive Biomarkers in Ovarian Cancers
Status: Recruiting
Last Changed: Feb 17, 2020
First Received: Jan 04, 2017
Disease(s): Ovarian Cancer
Intervention(s): Blood sample
Locations: Gustave Roussy, Villejuif, Val De Marne, France
Determining Prognostic Immune Markers in Patients With Ovarian Cancer
Status: Recruiting
Last Changed: Feb 21, 2020
First Received: Mar 05, 2019
Disease(s): Epithelial Ovarian Cancer
Intervention(s): No intervention
Locations: Leiden University Medical Center, Leiden, Netherlands
Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer
Status: Recruiting
Last Changed: Feb 12, 2020
First Received: Sep 13, 2019
Disease(s): Ovarian Cancer
Intervention(s): IMP4297
Locations: Xiaohua.Wu, Shanghai, China